Exp Mol Med.
2013 Jul;45(7):e31.
A known expressed sequence tag, BM742401, is a potent lincRNA inhibiting cancer metastasis
- Affiliations
-
- 1Medical Genomics Research Center, KRIBB, Daejeon, Republic of Korea. kimsy@kribb.re.kr
- 2Department of Functional Genomics, University of Science and Technology, Daejeon, Republic of Korea.
- 3Department of General Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- 4Department of Pathology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- 5Department of Pathology Thoracic, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Abstract
- Long intergenic non-coding RNAs (lincRNAs) have historically been ignored in cancer biology. However, thousands of lincRNAs have been identified in mammals using recently developed genomic tools, including microarray and high-throughput RNA sequencing (RNA-seq). Several of the lincRNAs identified have been well characterized for their functions in carcinogenesis. Here we performed RNA-seq experiments comparing gastric cancer with normal tissues to find differentially expressed transcripts in intergenic regions. By analyzing our own RNA-seq and public microarray data, we identified 31 transcripts, including a known expressed sequence tag, BM742401. BM742401 was downregulated in cancer, and its downregulation was associated with poor survival in gastric cancer patients. Ectopic overexpression of BM742401 inhibited metastasis-related phenotypes and decreased the concentration of extracellular MMP9. These results suggest that BM742401 is a potential lincRNA marker and therapeutic target.